1 New study at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual assembly, has chanced on that rheumatoid arthritis (RA) patients in sustained remission who stopped TNF inhibitors (TNFi) had a good deal more flares and lower Boolean 2.0 remission rates when in contrast with these that continued treatment…
Study More
Watch finds tapering TNF inhibitors will increase flares, lowers Boolean remission rates for RA patients in remission
